JOSHUA LORBACHER: Open Payments
NPI 1245976117 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,556 in 72 payments from 16 companies in 2025. Trend: 2023 $875 · 2024 $1,539 · 2025 $1,556
Food & beverage: $1,556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $360 |
| Janssen Biotech, Inc. | 7 | $265 |
| Ardelyx, Inc. | 9 | $137 |
| Aimmune Therapeutics, Inc. | 5 | $121 |
| GENZYME CORPORATION | 4 | $116 |
| Phathom Pharmaceuticals, Inc. | 5 | $100 |
| Madrigal Pharmaceuticals | 3 | $79 |
| Lilly USA, LLC | 3 | $71 |
| PFIZER INC. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
Products named: TREMFYA, DUPIXENT, IBSRELA, ZENPEP, MAVYRET, VOQUEZNA, LINZESS, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
